If the latest innovations in mascara and faux cils haven’t satisfied your lash-lengthening needs, the FDA has just approved the first-ever medical growth treatment for at-home use.
“LATISSE fulfills a significant and previously unmet need in the medical aesthetic marketplace with a product approved by the FDA that increases the growth of eyelashes, making them longer, thicker and darker,” said Scott Whitcup, M.D., Allergan’s Executive Vice President of Research and Development. “As the global
leader in medical aesthetics, LATISSE exemplifies our continuing commitment to developing innovative treatments that are studied in well-controlled clinical trials, manufactured to pharmaceutical standards, appropriately labeled for use, and available to consumers as a prescription product.”
Available only through a doctor, LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. Users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE is required. If use of LATISSE is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).
Based on their recent FDA approval, Allergan expects to launch the product nationwide in Spring 2009.
For additional information visit Latisse.com.